Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: methyl hydroxybenzoate; titanium dioxide; indigo carmine; gelatin; magnesium stearate; propyl hydroxybenzoate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: indigo carmine; methyl hydroxybenzoate; propyl hydroxybenzoate; gelatin; magnesium stearate; titanium dioxide; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - flucloxacillin sodium monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 27.2 mg/ml (equivalent: flucloxacillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: ammonium glycyrrhizinate; sodium benzoate; sucrose; saccharin sodium; disodium edetate; sodium citrate; erythrosine; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 54.4 mg/ml (equivalent: flucloxacillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: erythrosine; sodium citrate; sodium benzoate; sucrose; ammonium glycyrrhizinate; disodium edetate; saccharin sodium; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 1088.1 mg (equivalent: flucloxacillin, qty 1000 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 544.1 mg (equivalent: flucloxacillin, qty 500 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 545 mg (equivalent: flucloxacillin, qty 500 mg) - capsule, hard - excipient ingredients: povidone; titanium dioxide; purified talc; brilliant blue fcf; iron oxide red; magnesium stearate; iron oxide yellow; gelatin; microcrystalline cellulose; sodium starch glycollate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 272.5 mg (equivalent: flucloxacillin, qty 250 mg) - capsule, hard - excipient ingredients: povidone; brilliant blue fcf; magnesium stearate; sodium starch glycollate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; microcrystalline cellulose; gelatin - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - flucloxacillin sodium - oral capsule - 250mg